P/E ratio for Microbot Medical (MBOT)
P/E ratio as of May 2024 (TTM): -0.6755
According to Microbot Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.675473. At the end of 2022 the company had a P/E ratio of -1.66.
P/E ratio history for Microbot Medical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.66 | -64.74% |
| 2021 | -4.72 | -11.68% |
| 2020 | -5.34 | -10.19% |
| 2019 | -5.95 | 722.95% |
| 2018 | -0.7227 | -86.25% |
| 2017 | -5.26 | -60.18% |
| 2016 | -13.2 | 1136.43% |
| 2015 | -1.07 | -37.51% |
| 2014 | -1.71 | -13.85% |
| 2013 | -1.98 | 16.84% |
| 2012 | -1.70 | 206.45% |
| 2011 | -0.5541 | -89.53% |
| 2010 | -5.29 | 9.24% |
| 2009 | -4.85 | 21.15% |
| 2008 | -4.00 | -17.33% |
| 2007 | -4.84 | -56.18% |
| 2006 | -11.0 | -42.39% |
| 2005 | -19.2 | 40.46% |
| 2004 | -13.6 | 217.01% |
| 2003 | -4.30 | 81.65% |
| 2002 | -2.37 | -85.06% |
| 2001 | -15.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -3.33 | 393.48% | Bahamas |
 NRC Health
NRC | 26.4 | -4,001.40% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.